• Contact/
  • Home/

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • Advent Life Sciences
  • Advent Life Sciences

Page 17 of 24

 
<< Start < Prev 12 13 14 15 16 17 18 19 20 21Next >End >>
18.11.2011FDA approves Erwinaze to treat a form of leukemia

Press Release

18.11.2011EUSA Pharma Announces FDA Approval Of Orphan Drug ERWINAZE™ For Treatment Of Acute Lymphoblastic Leukemia

Press Release

18.11.2011Biocartis completes EUR 71 million (USD 100 million) Series C Fund Raising

Press Release

18.10.2011Cellnovo receives 2011 Best MedTech Fundraiser Award

Press Release

04.10.2011Frost & Sullivan has announced Cellnovo the winner of its 2011 European Technology Innovation Award in Diabetes Care

Press Release

19.09.2011Cellnovo Receives CE Mark Approval for World's First Mobile Diabetes Management System

Press Release

12.09.2011Cellnovo forms worldwide technology alliance with LifeScan

Press Release

01.09.2011Biocartis named as a Technology Pioneer 2012 by the World Economic Forum

Press Release

02.07.2011Cellnovo inVivo Article

In The News

10.06.2011Avila Therapeutics agreement with NIAID

Avila Therapeutics, Inc announces Non-Clinical Evaluation Agreement

Press Release



  • Privacy Policy
  • Legal and Regulatory Matters

©2022 Advent Life Sciences